CHECKOUT
Step 1/4
MRK
Merck
  • Vol:
 

Merck (MRK)

.

Merck (MRK) - Develops prescription drugs in the areas of diabetes, obesity, respiratory, cardiovascular, women's health.

 GROUP LEADERSHIP
Medical-Ethical Drugs Group
MRK
is ranked
#2
2nd in group
is ranked
#1
1st in group
 IBD RATINGS FOR MRK
  • Checklist
  • Rating

Take a Free Trial to see all ratings

MRK NEWS
  • MRK NEWS FROM IBD
  • MRK NEWS - IBD PARTNERS
IBD

Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat

Today's Dow Jones Stocks To Watch: Travelers Dives On Earnings

Which Blue Chip Led The Dow Jones Industrials In Q1?

Merck Stock Pops After Snagging Its Latest Approval; The First In A Possible $10 Billion 'Renaissance'

Moderna Nears Its First Breakout In Over A Year After Launching Third Cancer Vaccine Test

View All »

IBD Partners
No News Available.
 STOCK/COMPANY DATA FOR MRK
    Stock Data
  • Today's Range
  • 128.76  -  132.80
  • 52-Week Range
  • 99.14  -  133.10
  • Price % Chg. YTD
  • 19.9%
  • Price % Chg. Last 4 Weeks
  • 2.13%
  • 50-Day Avg. Volume
  • 8,524,500
  • Shares Outstanding
  • 2532.6 Mil
  • Float
  • 2507.3 Mil
  • IPO Date
  • N/A
  • Investment Bank
  • % Mgmt Owns
  • 1%
  • PE Ratio
  • 60
  • Dividend Yield
  • 2.4%
  • Alpha
  • 0.03
  • Beta
  • 0.29
    Company Fundamentals
  • EPS Due Date
  • 7/30/2024
  • EPS % Chg (Last Qtr)
  • 48%
  • 3 Year EPS Growth Rate
  • -25%
  • EPS Est % Chg (Current Yr)
  • 470%
  • Annual ROE
  • 9.2%
  • Sales % Chg (Last Qtr)
  • 9%
  • 3-Year Sales Growth Rate
  • 13%
  • Debt %
  • 90%
  • Market Cap
  • $331.1 B $331 Bil
  • Annual Pre -Tax Margin
  • 10.0%
  • Sector
  • medical
  • Industry Group
  • Medical-Ethical Drugs
  • Industry Group Rank
  • 113